Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 5th edition, 486 pages Free download

Gastric Cancer

Free Subscription 12.10.2020 1 BMC Surg 3 Cancer Lett 1 Gut 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Surg

1. LEE S, Lee H, Song JH, Choi S, et al
   Intracorporeal esophagojejunostomy using a linear stapler in laparoscopic total gastrectomy: comparison with circular stapling technique.
   BMC Surg. 2020;20:100.
   PubMed         Abstract available
   
   

   
   Cancer Lett

2. TANG H, Kong Y, Guo J, Tang Y, et al
   Corrigendum to "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22" [Canc. Lett. 340 (1) (Oct 28, 2013) 72-81].
   Cancer Lett. 2020 Oct 5. pii: S0304-3835(20)30356.
   PubMed        
   
   
3. WANG Y, Lu JH, Wang F, Wang YN, et al
   Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
   Cancer Lett. 2020;473:74-89.
   PubMed         Abstract available
   
   
4. TAM BY, Chiu K, Chung H, Bossard C, et al
   The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
   Cancer Lett. 2020;473:186-197.
   PubMed         Abstract available
   
   

   
   Gut

5. SO JBY, Kapoor R, Zhu F, Koh C, et al
   Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population.
   Gut. 2020 Oct 7. pii: gutjnl-2020-322065. doi: 10.1136/gutjnl-2020-322065.
   PubMed         Abstract available
   
   

   
   PLoS One

6. SASAKI N, Iwaya T, Chiba T, Fujita M, et al
   Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA.
   PLoS One. 2020;15:e0239966.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: